Kala Jayaram

Executive Medical Director, Pharmacovigilance
BioMarin Pharmaceutical Inc., Novato, CA, USA

Presentation(s):

• PB0210 - Blood Biodistribution and Vector Shedding of Valoctocogene Roxaparvovec in People with Severe Hemophilia A: Results from the Phase 3 GENEr8-1 Trial

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM